HIV

US funding remains frozen for many life-saving services

Despite waivers, court judgments and assurances from the embassy, USAID funding for projects that provide HIV medication has not resumed

By

News | 21 February 2025

HIV patients go weeks without medicines after US aid cut

Legal challenges have restored funding but damage has been done

By

News | 18 February 2025

Over 15,000 South African health workers’ jobs are at risk as US cuts aid

Some harm reduction and LGBTI services have already closed

By

News | 11 February 2025

Trump’s sudden suspension of foreign aid puts millions of lives in Africa at risk

Imprecise executive order leaves health providers dependent on PEPFAR funding unsure if or when money will arrive

By

News | 23 January 2025

Alarming rise in HIV among drug users as government fails to implement policy

Needle programs are officially supported, but the state often obstructs them

By

Feature | 21 October 2024

Vhutshilo Mountain School offers lifeline to AIDS orphans

Limpopo school has been going strong for nearly 20 years

By

News | 10 October 2024

How we know a new medicine is so effective at preventing HIV transmission

There was not a single HIV transmission in a clinical trial in which women volunteers used the twice-yearly injectable drug lenacapavir

By

Science | 1 August 2024

South Africans are living longer, mostly thanks to HIV treatment

Antiretroviral medicines have been a success, but more work is needed to reach United Nations targets

By and

Science | 1 December 2023

Court ruling means that pharmacists can prescribe to people with HIV

Specially trained pharmacists will be allowed to manage and prescribe medicine to patients with HIV and/or tuberculosis

By

Law | 15 August 2023

The maths that helped South Africa tackle HIV

UCT epidemiologist Leigh Johnson delivered GroundUp and Bertha House’s third Science for the People seminar

By

Science | 29 March 2023

Nontsikelelo Zwedala: an unsung hero of the struggle for HIV medicines

She was one of the complainants in a Competition Commission case that resulted in antiretroviral medicines becoming affordable

By

Obituary | 20 March 2023

Injections against HIV could be manufactured locally and cheaply, says Aspen Pharmacare

Cabotegravir is still unaffordable after two years

By

News | 1 December 2022

Good news: HIV medicine prices have decreased dramatically!

Experts commend the Department of Health’s efforts to secure lower prices in new contract

By

News | 16 November 2022

TAC slams Mbeki over his views on HIV

Former president repeated misconceptions about the disease when he addressed UNISA

By

News | 28 September 2022

HIV incidence in South Africa has halved since 2010

This is mainly due to antiretroviral treatment and condom promotion, but male medical circumcision and behaviour change after HIV diagnosis had a role too

By

Science | 9 February 2022

Law and power: How a prisoner’s journey saved the lives of thousands

A look back at the battle for the rights of HIV-positive prisoners

By

Analysis | 11 November 2021